- Investor's Business Daily•6 months ago
The buzz around biotechs amped up a notch in the past week as Kite Pharma (KITE) and G.W. Pharmaceuticals (GWPH) socked away double-digit gains. Kite soared 10% in massive trade on Tuesday after announcing its KTE-C19 treatment showed a 47% complete remission rate in patients with the most common form of Non-Hodgkin lymphoma. The stock quickly backed off to end...
- PR Newswire•6 months ago
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Raptor Pharmaceutical Corp. -RPTP
BALA CYNWYD, Pa., Sept. 20, 2016 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Raptor Pharmaceutical Corp. ("Raptor" ...
- Market Realist•6 months ago
The market was pleased with the merger deal between Horizon Pharma (HZNP) and Raptor Pharmaceuticals. HZNP shares rose to $18.89 on September 12.
RPTP : Summary for Raptor Pharmaceutical Corp. - Yahoo Finance
Raptor Pharmaceutical Corp. (RPTP)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|